CGM

Person wearing Jolly Good VR headset
By  Adam Ang 05:31 am November 3, 2023
Jolly Good developing CBT VR for Apple Vision Pro Japanese medical VR provider Jolly Good has announced that it is developing a virtual reality-based cognitive behavioural therapy (CBT) programme for the spatial computer Apple Vision Pro.  The CBT VR on the Apple Vision Pro is intended to complement chronic pain treatment using opioids or serve as an alternative non-drug therapy. Similar VR-based...
i-SENS CareSens Air CGM device and mobile app
By  Adam Ang 01:56 am June 23, 2023
The South Korean Ministry of Food and Drug Safety has approved the first locally-developed continuous glucose monitoring device. The CareSens Air, developed by blood glucose device maker i-SENS, is touted to be the smallest and lightest CGM device available in South Korea. It can also be used for 15 days straight and features a calibration mechanism to make readings more reliable.  Following this...
A Dexcom user checking their blood glucose level in real-time via mobile app
By  Adam Ang 01:55 am June 23, 2023
The digital healthcare business of South Korean internet company Kakao Corporation has entered into a collaboration agreement with Dexcom to set up a global digital diabetes management service. According to a press statement, the deal combines Kakao Healthcare's capabilities in AI and software technology with Dexcom's continuous glucose monitoring (CGM) devices, Dexcom G6 and G7, which the...
Dexcom G6 CGM system
By  Adam Ang 09:39 pm February 23, 2023
Dexcom takes G6 CGM to Singapore Global CGM device maker Dexcom has launched its latest CGM system in Singapore.  Distributed through its partner DKSH Singapore, the prick-less Dexcom G6 CGM uses a wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a compatible smart device. It pairs with a companion mobile app on iOS and Android devices, enabling the...
A close up of a person wearing a CGM while tracking glucose levels on their phone
By  Emily Olsen 10:45 am February 9, 2023
DarioHealth is partnering with Dexcom to integrate the company's continuous glucose monitors into Dario's chronic-condition management platform.  The collaboration will allow Dario's digital health tools for metabolic health to include data from Dexcom CGMs, wearable sensors that automatically monitor blood glucose levels for patients with diabetes. Dario said integrating CGM data would provide...
The Dexcom G7 alongside a smartphone and Apple Watch.
By  Emily Olsen 10:54 am December 13, 2022
Dexcom announced last week that its G7 continuous glucose monitoring system has received FDA clearance. The latest model of its CGM, which can be used by people with all types of diabetes ages 2 and up, is expected to launch in the U.S. early next year. As the company works out insurance coverage for the G7, it plans to offer cash payment options for early adopters. The CGM fits on the back of...
[Left] Anjan Bhojarajan, HealthifyMe Chief Business Officer, and [Right] Tushar Vashisht, HealthifyMe CEO
By  Adam Ang 05:02 am April 22, 2022
Indian health and fitness app HealthifyMe has launched a new offering that combines health tracking and smart diagnostics to deliver personalised fitness and nutrition plans. HealthifyPro is its latest flagship fitness plan that comes with a biosensor system of continuous glucose monitor (BIOS) and other sensors and body monitors; a connected Smart Scale metabolic panel; and support from in-house...
An older man wearing headphones checking his smartphone
By  Emily Olsen 12:14 pm February 14, 2022
Continuous glucose monitoring system maker Senseonics has won FDA approval for its Eversense E3, which can be used to measure glucose levels in adults with diabetes for up to six months. The system works using a sensor that is implanted just under the skin by a healthcare provider. A transmitter worn over the sensor, on top of the skin, receives glucose data, provides vibratory alerts and...
person on phone
By  Laura Lovett 01:57 pm January 13, 2022
At the J.P. Morgan Healthcare Conference this week, Dexcom, maker of continuous glucose monitoring systems, made waves after CEO Kevin Sayer announced new clinical trial data from its yet to be released CGM, the G7.  The 308 person trial demonstrated that the G7's mean absolute relative difference (MARD) was 8.2% for adults and 8.1% for pediatric patients. The G7 was submitted to the FDA in the...
CGM data from Abbott FreeStyle LibreLink integrates with Health2Sync
By  Adam Ang 12:20 am November 17, 2021
Taiwan-based diabetes management app Health2Sync has launched the latest version of its mobile app for about 200,000 users in Japan that now integrates continuous glucose monitoring data from the Abbott FreeStyle LibreLink mobile app. WHY IT MATTERS This data integration, said Health2Sync in a statement, will enable comprehensive health management for people with diabetes. It will allow them to...